122 related articles for article (PubMed ID: 12911945)
1. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent.
Dunkley SM; Mackie F
Hematology; 2003 Aug; 8(4):263-4. PubMed ID: 12911945
[TBL] [Abstract][Full Text] [Related]
2. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
Grounds M
Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
[TBL] [Abstract][Full Text] [Related]
4. Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation.
Dominguez TE; Mitchell M; Friess SH; Huh JW; Manno CS; Ravishankar C; Gaynor JW; Tabbutt S
Pediatr Crit Care Med; 2005 May; 6(3):348-51. PubMed ID: 15857537
[TBL] [Abstract][Full Text] [Related]
6. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
7. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
8. The use of recombinant factor VIIa for bleeding in paediatric practice.
Millar CG; Stringer MD; Sugarman I; Richards M
Haemophilia; 2005 Mar; 11(2):171-4. PubMed ID: 15810920
[TBL] [Abstract][Full Text] [Related]
9. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Payne EM; Brett SJ; Laffan MA
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
MartÃnez J; Cid AR; de la Rubia J; Gimeno R
Blood Coagul Fibrinolysis; 2005 Jun; 16(4):297-9. PubMed ID: 15870551
[TBL] [Abstract][Full Text] [Related]
12. Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa.
Pastores SM; Papadopoulos E; Voigt L; Halpern NA
Chest; 2003 Dec; 124(6):2400-3. PubMed ID: 14665531
[TBL] [Abstract][Full Text] [Related]
13. 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective.
Clark AD; Gordon WC; Walker ID; Tait RC
Vox Sang; 2004 Feb; 86(2):120-4. PubMed ID: 15023181
[TBL] [Abstract][Full Text] [Related]
14. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
15. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Blatt J; Gold SH; Wiley JM; Monahan PE; Cooper HC; Harvey D
Bone Marrow Transplant; 2001 Aug; 28(4):405-7. PubMed ID: 11571515
[TBL] [Abstract][Full Text] [Related]
16. Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
Dhruva KK; Joel VD; Antony S; Vinodan K
J Indian Med Assoc; 2006 Jan; 104(1):42, 44. PubMed ID: 16850866
[TBL] [Abstract][Full Text] [Related]
17. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
18. Use of recombinant factor VIIa (rFVIIa) in the management of intractable haemorrhage: a survey of current UK practice.
Biss TT; Hanley JP
Br J Haematol; 2007 Jul; 138(1):126-8. PubMed ID: 17555457
[No Abstract] [Full Text] [Related]
19. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
Mathew P; Young G
Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
